Waterstone Technology

Waterstone Pharmaceuticals is a private pharmaceutical and biotech company with U.S. roots and major research, development, and manufacturing operations in Wuhan, China. The company appears to be the healthcare-related business associated with the requested name "Waterstone Technology," which is used for its U.S. entity and chemical supply operation. Waterstone works across proprietary drug discovery, custom development and manufacturing, generic drug development, and supply of specialty chemicals, API reference compounds, and linker-payload materials for drug developers. Its disclosed pipeline includes WS016, a polymer-based potassium binder for hyperkalemia, and the company has highlighted a broader focus on metabolic and kidney diseases, including diabetic kidney disease. Waterstone also offers manufacturing and development capabilities relevant to small molecules, polymer intermediates, high-end formulations, and ADC linker-payload supply.